Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of High Spatial Resolution PM<sub>2.5</sub>, PM<sub>10</sub>, and NO<sub>2</sub> Estimates Using a Deep Ensemble Machine Learning Framework in a Low Pollution Setting.

Environmental science & technology·2026
Same author

The United States' Withdrawal from the WHO is a Risk the World Cannot Afford.

American journal of respiratory and critical care medicine·2026
Same author

Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021.

The Medical journal of Australia·2026
Same author

All hands to the wheel to change course on the strategy for TB control.

American journal of respiratory and critical care medicine·2026
Same author

Worldwide Impact of Human Development and Inequality on the Prevalence of Asthma, Rhinoconjunctivitis and Eczema. Global Asthma Network's Ecological Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Source-specific short-term-ozone exposure and specific cancer mortality risk: A multi-country study in 11,215 communities.

Journal of hazardous materials·2026

Related Experiment Videos

Associations between statins and COPD: a systematic review.

Claudia C Dobler1, Keith K Wong, Guy B Marks

  • 1Woolcock Institute of Medical Research, Sydney, New South Wales, Australia. c.dobler@unsw.edu.au

BMC Pulmonary Medicine
|July 15, 2009
PubMed
Summary
This summary is machine-generated.

Statins may reduce mortality and illness in chronic obstructive pulmonary disease (COPD) patients, according to observational studies and one randomized controlled trial. Further research is needed to confirm these positive effects of statin treatment in COPD.

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Pulmonology
  • Clinical Medicine

Background:

  • Statins possess anti-inflammatory and immunomodulating properties.
  • These properties may influence inflammatory airway diseases like COPD.
  • Evidence for disease-modifying effects of statins in COPD patients was assessed.

Purpose of the Study:

  • To assess the evidence for disease-modifying effects of statin treatment in patients with chronic obstructive pulmonary disease (COPD).

Main Methods:

  • A systematic review of studies on statin treatment in COPD was conducted.
  • Searched databases included MEDLINE, EMBASE, and reference lists.
  • Nine original studies, including one RCT and various observational designs, met selection criteria.

Main Results:

  • Statins were associated with decreased all-cause mortality (3/4 studies) and COPD-related mortality.
  • Reduced respiratory-related urgent care, COPD exacerbations, and intubations were observed.
  • One RCT showed improved exercise capacity and reduced C-reactive protein/Interleukin-6, but no lung function improvement.

Conclusions:

  • Observational studies and one RCT suggest statins may reduce morbidity and/or mortality in COPD patients.
  • Further interventional studies are required to confirm these findings.
  • Statins show potential as a therapeutic option for managing COPD.